Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa-Reference-Cited by-同舟云学术

Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa

Published:2022-02 Issue:2 Volume:22 Page:284-294
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Cooper Laura V,Bandyopadhyay Ananda S,Gumede Nicksy,Mach Ondrej,Mkanda Pascal,Ndoutabé Modjirom,Okiror Samuel O,Ramirez-Gonzalez Alejandro,Touray Kebba,Wanyoike Sarah,Grassly Nicholas C,Blake Isobel M

Funder

Bill & Melinda Gates Foundation

World Health Organization

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference27 articles.

1. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine—worldwide, 2016;Hampton;MMWR Morb Mortal Wkly Rep,2016

2. Modeling the dynamics of oral poliovirus vaccine cessation;Thompson;J Infect Dis,2014

3. The risk of type 2 oral polio vaccine use in post-cessation outbreak response;McCarthy;BMC Med,2017

4. WHO keeps polio on the international health emergency list;Zarocostas;Lancet,2018

5. Lessons learned from managing the planning and implementation of inactivated polio vaccine introduction in support of the polio endgame;Zipursky;J Infect Dis,2017

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation of the poliovirus type 2 immunity gap in South Africa;Vaccine;2024-10

2. Identifying and reducing risks of neurological complications associated with vaccination;Nature Reviews Neurology;2024-08-07

3. Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria;Vaccine: X;2024-06

4. Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine;BMC Infectious Diseases;2024-05-28

5. Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020–2024;Pathogens;2024-05-22